Global Bronchiectasis Drugs Market Size, Industry Trends, Share and Forecast 2021-2027
The global bronchiectasis drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Some pivotal factors that are driving the market growth include the high presence of bronchiectasis among the public and the improved infrastructure facilities in the healthcare and medical sector. Another key factor anticipate to drive the market growth include the constant R&D in the field of bronchiectasis drugs coupled with the rising competition among established drug makers.
Under the global
bronchiectasis drugs market, the major types of drugs available include
antibiotics and expectorants. Among these two, antibiotics have the greater
demand and are anticipated to continue to stay ahead of the expectorant segment
in the future years. An increase in the number of respiratory diseases has been
driving the antibiotics demand. In addition, the low cost and easy availability
of these antibiotics have led to the demand substantially as well.
To Request a Sample of our Report on Global Bronchiectasis
Drugs Market: https://www.omrglobal.com/request-sample/bronchiectasis-drugs-market
Some key players operating in the market include Endo International Plc,
GlaxoSmithKline Plc,., Reckitt and Benckiser Group Plc, among others. These
players are eyeing to strengthen their position in the market by adopting
various strategies as mergers and acquisitions, partnerships, collaborations,
new product launch and development in the existing product portfolio, and so
on. For instance, in April 2014, Bayer HealthCare announced that the US Food
and Drug Administration's (FDA) Office of Orphan Products Development has
granted orphan drug designation for its investigational Ciprofloxacin Dry
Powder for Inhalation (Ciprofloxacin DPI) for the treatment of non-cystic
fibrosis bronchiectasis (NCFB). Such approvals for the novel forms of drugs
from the FDA for the treatment of bronchiectasis are further anticipated to
drive the market growth during the forecast period.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: Endo International Plc,
GlaxoSmithKline Plc,., Reckitt and Benckiser Group Plc, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Global Bronchiectasis Drugs Market is Available at: https://www.omrglobal.com/industry-reports/bronchiectasis-drugs-market
Global Bronchiectasis Drugs Market by Segmentation
By Product
• Antibiotics
• Expectorants
• Other Drugs
Global Bronchiectasis Drugs Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment